Laura Alice David
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Alice David has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Martinsson
University of Gothenburg
2 shared publications Amar Taha
Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden
1 shared publication- Amar Taha
University of Gothenburg
1 shared publication - Anders Jeppsson
Sahlgrenska University Hospital
1 shared publication Araz Rawshani
University of Gothenburg
1 shared publication- Björn Redfors
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
1 shared publication
Latest Publications
- Open Access
Permanent pacemaker implantation after cardiac surgery and long-term outcome
Background: Patients undergoing cardiac surgery are at risk of perioperative conduction system damage leading to permanent placement of a cardiac electronic implantable device (CIED) which is a common complication following cardiac surgery. Studies evaluating the long-term outcomes following permanent pacemaker implantation in cardiac surgery patients are contradictory and inconsistent. The current study aimed to evaluate the long-term outcome across the spectrum of cardiac surgery in a nationwide contemporary setting. Methods: All adult patients in Sweden, without previous CIED who had cardiac surgery between 2006 and 2020 were included. Data was obtained from nationwide registries. Cox proportional hazards models were used to account for comorbid conditions and perioperative characteristics and to evaluate the association between permanent pacemaker or implantable cardioverter defibrillator (ICD) implantation and the risk of all-cause mortality, cardiovascular mortality and heart failure hospitalisation. Results: Among 76 223 patients (mean age 67.8 years, 25% female), 2150 (2.8%) received a permanent pacemaker and 348 (0.5%) received an ICD within 30 days after surgery. During a mean follow-up of 6.8 years (SD 10.7), pacemaker implantation was associated with a higher risk of all-cause mortality (adjusted HR (aHR) 1.09, 95% CI 1.01 to 1.19) and heart failure hospitalisation (aHR 1.36, 95% CI 1.22 to 1.52). Cardiovascular mortality showed a similar but statistically non-significant trend. ICD implantation was not associated with all-cause mortality but was associated with increased risks of heart failure hospitalisation and cardiovascular mortality. Subgroup analyses did not show any significant interactions between comorbid conditions and outcomes. Conclusion: Permanent pacemaker implantation after cardiac surgery was associated with a higher risk of all-cause mortality and heart failure hospitalisation. These findings were consistent across cardiac surgical subtypes and underscore the need for careful long-term surveillance for these patients.
Open AccessPermanent pacemaker implantation after cardiac surgery and long-term outcome
Background: Patients undergoing cardiac surgery are at risk of perioperative conduction system damage leading to permanent placement of a cardiac electronic implantable device (CIED) which is a common complication following cardiac surgery. Studies evaluating the long-term outcomes following permanent pacemaker implantation in cardiac surgery patients are contradictory and inconsistent. The current study aimed to evaluate the long-term outcome across the spectrum of cardiac surgery in a nationwide contemporary setting. Methods: All adult patients in Sweden, without previous CIED who had cardiac surgery between 2006 and 2020 were included. Data was obtained from nationwide registries. Cox proportional hazards models were used to account for comorbid conditions and perioperative characteristics and to evaluate the association between permanent pacemaker or implantable cardioverter defibrillator (ICD) implantation and the risk of all-cause mortality, cardiovascular mortality and heart failure hospitalisation. Results: Among 76 223 patients (mean age 67.8 years, 25% female), 2150 (2.8%) received a permanent pacemaker and 348 (0.5%) received an ICD within 30 days after surgery. During a mean follow-up of 6.8 years (SD 10.7), pacemaker implantation was associated with a higher risk of all-cause mortality (adjusted HR (aHR) 1.09, 95% CI 1.01 to 1.19) and heart failure hospitalisation (aHR 1.36, 95% CI 1.22 to 1.52). Cardiovascular mortality showed a similar but statistically non-significant trend. ICD implantation was not associated with all-cause mortality but was associated with increased risks of heart failure hospitalisation and cardiovascular mortality. Subgroup analyses did not show any significant interactions between comorbid conditions and outcomes. Conclusion: Permanent pacemaker implantation after cardiac surgery was associated with a higher risk of all-cause mortality and heart failure hospitalisation. These findings were consistent across cardiac surgical subtypes and underscore the need for careful long-term surveillance for these patients.
- Open Access
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e048153
Infective Endocarditis After Arrythmia Device Implantation in Cardiac Surgery Patients
Background: Patients undergoing cardiac surgery face an increased risk of infective endocarditis (IE), a risk that may be further exacerbated by implantation of cardiac implantable electronic devices (CIED). This study aimed to assess the risk of IE after CIED implantation within 30 days of cardiac surgery and identify associated risk factors. Methods: All patients in Sweden, with no previous CIED, who underwent first‐time cardiac surgery between 2006 and 2020 were included in this nationwide registry‐based study. Cox proportional hazards models adjusted for demographic and clinical covariates were used to estimate the association between CIED implantation and the risk of IE. Results: Out of 73 367 patients, 2302 (3.1%) received a CIED within 30 days. Over a median follow‐up of 6.5 years (interquartile range, 3.2–10.1 years), 1556 patients (2.1%) developed IE. CIED implantation was associated with an increased IE risk (adjusted hazard ratio [aHR], 1.46 [95% CI, 1.20–1.77]). Patients with IE had a significantly higher risk of mortality compared with those without IE (aHR, 1.80 [95% CI, 1.67–1.94]; P <0.001). The type of cardiac surgery influenced IE risk, with valvular surgeries showing a higher incidence than coronary artery bypass grafting. Risk factors independently associated with IE included male sex, age at surgery, diabetes, and peripheral vascular disease. Conclusions: CIED implantation within 30 days after cardiac surgery is associated with an increased long‐term risk of IE and subsequent mortality. The type of surgery and patient comorbidities influence the risk.
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e048153
Open AccessInfective Endocarditis After Arrythmia Device Implantation in Cardiac Surgery Patients
Background: Patients undergoing cardiac surgery face an increased risk of infective endocarditis (IE), a risk that may be further exacerbated by implantation of cardiac implantable electronic devices (CIED). This study aimed to assess the risk of IE after CIED implantation within 30 days of cardiac surgery and identify associated risk factors. Methods: All patients in Sweden, with no previous CIED, who underwent first‐time cardiac surgery between 2006 and 2020 were included in this nationwide registry‐based study. Cox proportional hazards models adjusted for demographic and clinical covariates were used to estimate the association between CIED implantation and the risk of IE. Results: Out of 73 367 patients, 2302 (3.1%) received a CIED within 30 days. Over a median follow‐up of 6.5 years (interquartile range, 3.2–10.1 years), 1556 patients (2.1%) developed IE. CIED implantation was associated with an increased IE risk (adjusted hazard ratio [aHR], 1.46 [95% CI, 1.20–1.77]). Patients with IE had a significantly higher risk of mortality compared with those without IE (aHR, 1.80 [95% CI, 1.67–1.94]; P <0.001). The type of cardiac surgery influenced IE risk, with valvular surgeries showing a higher incidence than coronary artery bypass grafting. Risk factors independently associated with IE included male sex, age at surgery, diabetes, and peripheral vascular disease. Conclusions: CIED implantation within 30 days after cardiac surgery is associated with an increased long‐term risk of IE and subsequent mortality. The type of surgery and patient comorbidities influence the risk.